ULTIMOVACS ASA (ULTI.OL) Fundamental Analysis & Valuation

OSL:ULTI • NO0010851603

Current stock price

2.11 NOK
-0.07 (-3.21%)
Last:

This ULTI.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ULTI.OL Profitability Analysis

1.1 Basic Checks

  • In the past year ULTI has reported negative net income.
  • In the past year ULTI has reported a negative cash flow from operations.
  • ULTI had negative earnings in each of the past 5 years.
  • ULTI had a negative operating cash flow in each of the past 5 years.
ULTI.OL Yearly Net Income VS EBIT VS OCF VS FCFULTI.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -173.53%, ULTI is doing worse than 79.73% of the companies in the same industry.
  • ULTI's Return On Equity of -243.21% is on the low side compared to the rest of the industry. ULTI is outperformed by 71.62% of its industry peers.
Industry RankSector Rank
ROA -173.53%
ROE -243.21%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ULTI.OL Yearly ROA, ROE, ROICULTI.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • ULTI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ULTI.OL Yearly Profit, Operating, Gross MarginsULTI.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ULTI.OL Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for ULTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ULTI.OL Yearly Shares OutstandingULTI.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ULTI.OL Yearly Total Debt VS Total AssetsULTI.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

  • ULTI has an Altman-Z score of -8.58. This is a bad value and indicates that ULTI is not financially healthy and even has some risk of bankruptcy.
  • ULTI's Altman-Z score of -8.58 is on the low side compared to the rest of the industry. ULTI is outperformed by 72.97% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that ULTI is not too dependend on debt financing.
  • ULTI has a better Debt to Equity ratio (0.00) than 91.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.58
ROIC/WACCN/A
WACCN/A
ULTI.OL Yearly LT Debt VS Equity VS FCFULTI.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • ULTI has a Current Ratio of 3.62. This indicates that ULTI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.62, ULTI is doing good in the industry, outperforming 70.27% of the companies in the same industry.
  • A Quick Ratio of 3.62 indicates that ULTI has no problem at all paying its short term obligations.
  • ULTI's Quick ratio of 3.62 is fine compared to the rest of the industry. ULTI outperforms 70.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.62
ULTI.OL Yearly Current Assets VS Current LiabilitesULTI.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ULTI.OL Growth Analysis

3.1 Past

  • The earnings per share for ULTI have decreased by -5.77% in the last year.
EPS 1Y (TTM)-5.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ULTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.48% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y51.29%
EPS Next 2Y43.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ULTI.OL Yearly Revenue VS EstimatesULTI.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2025 2026 10M 20M 30M 40M 50M
ULTI.OL Yearly EPS VS EstimatesULTI.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. ULTI.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • ULTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ULTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ULTI.OL Price Earnings VS Forward Price EarningsULTI.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ULTI.OL Per share dataULTI.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

  • ULTI's earnings are expected to grow with 43.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.48%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ULTI.OL Dividend Analysis

5.1 Amount

  • No dividends for ULTI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ULTI.OL Fundamentals: All Metrics, Ratios and Statistics

ULTIMOVACS ASA

OSL:ULTI (3/4/2025, 10:37:28 AM)

2.11

-0.07 (-3.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)02-13
Earnings (Next)05-08
Inst Owners18.55%
Inst Owner ChangeN/A
Ins Owners6.3%
Ins Owner ChangeN/A
Market Cap426.79M
Revenue(TTM)N/A
Net Income(TTM)-201.06M
Analysts42.22
Price Target6.29 (198.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-11.83%
EPS NY rev (3m)-92.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-75.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.16
P/tB 5.16
EV/EBITDA N/A
EPS(TTM)-5.81
EYN/A
EPS(NY)-2.12
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.81
OCFYN/A
SpS0
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -173.53%
ROE -243.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.62
Altman-Z -8.58
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2.96%
Cap/Depr(5y)41.24%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.69%
EPS Next Y51.29%
EPS Next 2Y43.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.92%
OCF growth 3YN/A
OCF growth 5YN/A

ULTIMOVACS ASA / ULTI.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ULTIMOVACS ASA (ULTI.OL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ULTI.OL.


What is the valuation status of ULTIMOVACS ASA (ULTI.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ULTIMOVACS ASA (ULTI.OL). This can be considered as Overvalued.


What is the profitability of ULTI stock?

ULTIMOVACS ASA (ULTI.OL) has a profitability rating of 0 / 10.


Can you provide the financial health for ULTI stock?

The financial health rating of ULTIMOVACS ASA (ULTI.OL) is 4 / 10.